<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Article Authoring DTD v1.4 20240229//EN" "JATS-articleauthoring1.dtd">
<article article-type="research-article" xml:lang="zh-CN" xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">16</journal-id>
      <journal-title-group>
        <journal-title>《当代医学论坛》（原当代医学）</journal-title>
      </journal-title-group>
      <issn>ISSN:3079-9260（原2717-5286）</issn>
      <publisher>
        <publisher-name>华文科学出版社</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.12421/ddyx3079-9260-202603113</article-id>
      <article-id pub-id-type="publisher-id">29922</article-id>
      <title-group>
        <article-title>夫那奇珠单抗治疗泛发性脓疱型银屑病 1 例</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>查天香</string-name>
        </contrib>
        <contrib contrib-type="author">
          <string-name>王霞</string-name>
        </contrib>
        <contrib contrib-type="author">
          <string-name>褚晓莉</string-name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub">
        <year>2026</year>
        <month>3</month>
      </pub-date>
      <issue>3</issue>
      <abstract>
        <p>目的：有文献报道脓疱型银屑病的发生和发展与 IL-17A 有关,使用 IL-17A 拮抗剂可一定程度上逆转银屑病
的分子生物学过程,从而改善患者的临床症状[1]｡ 本文将夫那奇珠单抗治疗脓疱型银屑病进展进行综述,结论:通
过夫那奇珠单抗注射液治疗,皮损好转效果明显,提高患者生活质量｡</p>
      </abstract>
    </article-meta>
  </front>
</article>
